Trinity Biotech
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Ireland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Ida Business Park, Bray, Leinster, A98 H...Phone Number
+353 8003253424Website
www.trinitybiotech.comRevenue
$61.6 MillionStock Symbol
TRIBIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Trinity Biotech
Trinity Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has recently entered the wearable biosensor industry, with the acquisition of the biosensor assets of Waveform Technologies Inc. and intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Our products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States and through a network of international distributors and strategic partners in over 75 countries worldwide.Explore more
Trinity Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Trinity Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Trinity Biotech had a recent Job posting/layoffs
Product Launch: Get notified when Trinity Biotech launches new products
Check if Trinity Biotech has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Trinity Biotech
Trinity Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Trinity Biotech recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Trinity Biotech has new funding data
Check out if Trinity Biotech is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Trinity Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Trinity Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Trinity Biotech.
Trinity Biotech financials insights
Gather financial insights about Trinity Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$115M
2022
Corporate Investment
$45M
2023
Debt
$5M
2024
Other Financing Round
$5.5M
2025
Debt
$4M
Debt
$5M
2026
Unspecified
$25M
Trinity Biotech Tech Stack
A closer look at the technologies used by Trinity Biotech
Most Recent Scoops
Person-Based
Medical Research
Person-Based
Product Launch, Machine Learning, Medical Research, Clinical Operations
Person-Based
Partnership, Medical Research
Person-Based
Partnership, Product Development, Medical Research
Person-Based
Trinity Biotech News & Media
Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results
– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targetsTrinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations
- Appointment supports revenue quality and profitability momentum as the Company activates its transformed operating baseTrinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test
DUBLIN and NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a global diagnostics company, today announced successful results from a clinical study of a new, enhanced version of its EpiCapture™ prostate cancer test, engineered to deliver higher precision risk prediction of aggressive prostate cancer.Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren’s Syndrome
DUBLIN and NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has entered into a collaboration agreement with the University at Buffalo, New York (“UB”). The partnership focuses on advancing and commercializing a suite of proprietary biomarkers for the earlier and more accurate detection of Sjögren’s Syndrome, one
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Trinity Biotech
Sign Up For FreeTo access detailed company insights
Trinity Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic... Read More
